First-ever malaria vaccine recommendation published in a position paper and in the WHO guidelines for malaria
On Mar. 4, 2022, the WHO announced it had published an updated position paper on the RTS,S/AS01 (RTS,S)…
Gavi approved malaria vaccine programme funding
On Dec. 3, 2021, Gavi, the Vaccine Alliance, approved a new malaria vaccination programme to support the introduction,…
Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
WHO recommended groundbreaking malaria vaccine for children at risk
On Oct. 6, 2021, the World Health Organization recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among…
The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
Monoclonal antibody prevented malaria in small NIH trial
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
Investigational malaria vaccine gives strong, lasting protection
On Jun. 30, 2021, the National Institutes of Health announced that two U.S. Phase 1 clinical trials of…
From 30 million cases to zero: China certified malaria-free by WHO
On Jun. 30, 2021, following a 70-year effort, China was awarded a malaria-free certification from the World Health…
RTS,S malaria vaccine reached more than 650 000 children in Ghana, Kenya and Malawi through pilot programme
On Apr. 20, 2021, the World Health Organization (WHO) announced that two years on from the launch of…
WHO announced position on genetically modified mosquitoes
On Oct. 14, 2020, recognizing the urgent need for new tools to combat vector-borne diseases (VBDs), and in…
NIH researchers discovered new set of channels connecting malaria parasite and blood cells
On Jul. 30, 2020, researchers at the National Institutes of Health and other institutions announced they had discovered…
The FDA approved only drug in U.S. to treat severe malaria
On May 26, 2020, the FDA approved Amivas’ artesunate for injection to treat severe malaria in adult and…
The FDA approved only drug in the U.S. to treat severe malaria
On May 26, 2020, the FDA provided approval to Amivas for its artesunate for injection to treat severe…
Global study tested malaria drug to protect health workers from COVID-19
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
NIH began clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
Hydroxychloroquine study reported no benefit from malaria drug in Veteran Affairs virus study
On Apr. 21, 2020, a study posted on medRxiv found no evidence that use of hydroxychloroquine, either with…
Washington University launched Clinical trial to evaluate COVID-19 treatment
On Apr. 9, 2020, Washington University School of Medicine in St. Louis launched a clinical trial for patients…
Mateon expanded its COVID-19 therapeutic program to include Artemisinin
On Apr. 8, 2020, Mateon Therapeutics announced that its COVID-19 directed antiviral screening program discovered that Artemisinin is…
PATH-led study found commercially available reference diagnostic detected malaria with whole blood sample
On Apr. 1, 2020, new evidence in The American Journal of Tropical Medicine and Hygiene suggested that the…
Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
NIH announced $1 million prize competition to target global disease diagnostics
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
WHO announced a vector alert for Anopheles stephensi invasion and spread
On Aug. 26. 2019, the World Health Organization announced a vector alert for Anopheles stephensi invasion and spread,…
The only FDA approved IV antimalarial in the US, IV quinidine, was discontinued
In Mar. 29, 2019, the Centers for Disease Control and Prevention (CDC) issued new guidance to clinicians for…
Tu Youyou won a share of the Nobel Prize in Physiology or Medicine for her discoveries concerning a novel therapy against Malaria
On Oct. 5, 2015, Tu Youyou was awarded a half share of the Nobel Prize in Physiology or…
Whole-genome sequences of 16 different mosquito species published in Science
On Nov. 27, 2014, two papers were published in Science that announced the completion and preliminary analyses of…
World Malaria Day established by the United Nations
On Apr. 25, 2008, marked the first-ever World Malaria Day established by the United Nations to ensure that…
Researchers led by Dr. Lakshmi Kotra discovered a new anti-malaria agent, KP-15
On Feb. 12, 2007, a study published in the Journal of Medicinal Chemistry by researchers led by Dr….
UC-Berkeley researchers created affordable anti-malaria drug artemisinin
On Apr. 12, 2006, chemical engineer Jay Keasling helped create an affordable anti-malaria drug, artemensins, by producing arteminsic…
Malaria Atlas Project was founded
In 2006, the Malaria Atlas Project (MAP) was founded as an international research collaboration that tracks the global…
The Bill & Melinda Gates Foundation announced grants totaling $258 million to develop a malaria vaccine
On Oct. 30, 2005, the Bill & Melinda Gates Foundation announced three grants totaling $258.3 million for advanced…